| Literature DB >> 26900954 |
Aline Coqueiro1,2,3, Young H Choi1, Robert Verpoorte1, Karthick B S S Gupta4, Maria De Mieri5, Matthias Hamburger5, Maria C M Young6, Paul Stapleton2, Simon Gibbons2, Vanderlan da S Bolzani3.
Abstract
Bioactivity-guided fractionation of the EtOH extract of the branches of Kielmeyera variabilis led to the isolation of a new acylphoroglucinol (1), which was active against all the MRSA strains tested herein, with pronounced activity against strain EMRSA-16. Compound 1 displayed an MIC of 0.5 mg/L as compared with an MIC of 128 mg/L for the control antibiotic norfloxacin. The structure of the new compound was elucidated by 1D and 2D NMR spectroscopic analysis and mass spectrometry, and experimental and calculated ECD were used to determine the absolute configurations. The compounds β-sitosterol (2), stigmasterol (3), ergost-5-en-3-ol (4), and osajaxanthone (5) also occurred in the n-hexane fraction. The EtOAc fraction contained nine known xanthones: 3,6-dihydroxy-1,4,8-trimethoxyxanthone (6), 3,5-dihydroxy-4-methoxyxanthone (7), 3,4-dihydroxy-6,8-dimethoxyxanthone (8), 3,4-dihydroxy-2-methoxyxanthone (9), 5-hydroxy-1,3-dimethoxyxanthone (10), 4-hydroxy-2,3-dimethoxyxanthone (11), kielcorin (12), 3-hydroxy-2-methoxyxanthone (13), and 2-hydroxy-1-methoxyxanthone (14), which showed moderate to low activity against the tested MRSA strains.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26900954 DOI: 10.1021/acs.jnatprod.5b00858
Source DB: PubMed Journal: J Nat Prod ISSN: 0163-3864 Impact factor: 4.050